MS Research Spotlight: 25 Years of Research, TWEAK Biomarker, and More
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Zhang, Y., Salter, A., Wallström, E., Cutter, G., & Stüve, O. (2019). Evolution of clinical trials in multiple sclerosis. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756286419826547
- Maarouf, A., Stephan, D., Ranjeva, MP. et al. (2019, December). High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis. Journal of Translational Medicine. 17: 51. https://doi.org/10.1186/s12967-019-1789-3
- University of Freiburg. (2019, February 19). Scientists create new map of brain's immune system. ScienceDaily. Retrieved March 13, 2019 from www.sciencedaily.com/releases/2019/02/190219132853.htm
- Landmark Study Estimates Nearly 1 Million in the U.S. Have Multiple Sclerosis. National Multiple Sclerosis Society. https://www.nationalmssociety.org/About-the-Society/News/Landmark-Study-Estimates-Nearly%C2%A01-Million-in-the-U. Published February 15, 2019. Accessed March 13, 2019.